ORYZON to present at upcoming international conferences


• IASLC 20th World Conference on Lung Cancer (WCLC 2019) in Barcelona, Spain

• 32nd European College of Neuropsychopharmacology (ECNP) Congress in Copenhagen, Denmark

• Rodman & Renshaw 21st Annual Global Investment Conference in NY, USA

• 20th International Conference on Alzheimer’s Drug Discovery in Jersey City, NJ, USA

• XV International Pharma Licensing Symposium in Paris, France

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that Executive Directors of the company will present at several reputed international conferences in September.


Click here to see the full Press Release